| Bioactivity | MIP-1072 is a small molecule specific prostate-specific membrane antigen (PSMA) inhibitor. MIP-1072 inhibits the glutamate carboxypeptidase activity of PSMA with an Ki value of 4.6 nmol/L. MIP-1072 is promising for research of prostate cancer[1]. |
| CAS | 949575-20-6 |
| Formula | C19H26IN3O7 |
| Molar Mass | 535.33 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Hillier SM, et al. Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer. Cancer Res. 2009 Sep 1;69(17):6932-40. |
MIP-1072
CAS: 949575-20-6 F: C19H26IN3O7 W: 535.33
MIP-1072 is a small molecule specific prostate-specific membrane antigen (PSMA) inhibitor. MIP-1072 inhibits the glutama
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.